Abstract
In the US, epilepsy is credited with 2.75 deaths per 1 million people. This number is slightly lower in the UK at 1.79, but higher in Canada at 6.74. (4) Surgery for intractable epilepsy has been in use for hundreds of years, and in recent decades has demonstrated good success. However, many practitioners and the public still view surgery as a last resort, to be explored only after all possible medical therapy combinations have been exhausted and a good length of time has elapsed. Now, however, many major centers have begun to push surgery further and further to the front of their treatment paradigm, predicated on the discovery that medical refractiveness can be predicted after failure of just a few medications. (1) As collective experience grows, the idea that surgery should be planned early in the disease course is gaining momentum. Now that surgical success rates can top 80% in carefully selected cases (2), the American Academy of Neurology, in association with the American Epilepsy Society and American Association of Neurological Surgeons, after reviewing one class 1 and 24 class 4 studies, recommend referral to an epilepsy center so that patients can be expediently evaluated for surgery. (3) Not only is the length of preoperative disease decreasing in these patients, but they are becoming younger. This raises the question: how early is too early? Even if early intervention makes sense in adults, is there a minimum age for which this holds true? Does intervention before this age cause increased harm? Several studies examining this area were reviewed, which in combination demonstrate that seizure surgery in young patients is efficacious. At Dell Children's Medical Center, we advocate early evaluation and surgery for patients with medically refractory epilepsy who are candidates. In the last two years we have done 17 surgeries on patients under 4 years of age, 3 of which have been on patients under one year. Once a patient is deemed medically refractory with a high likelihood of surgical benefit and acceptable surgical risk, we will proceed with surgery regardless of age. Patient selection, however, requires the coordinated effort of a quality multidisciplinary team.
Keywords: Epilepsy Surgery, Pediatric, Infant, Surgery Outcomes, Refractory Epilepsy, Multidisciplinary
Current Pediatric Reviews
Title: How Early is Too Early? A Review of Infant Seizure Surgery Literature
Volume: 8 Issue: 1
Author(s): Theodore J. Spinks, Mark R. Lee and Dave Clarke
Affiliation:
Keywords: Epilepsy Surgery, Pediatric, Infant, Surgery Outcomes, Refractory Epilepsy, Multidisciplinary
Abstract: In the US, epilepsy is credited with 2.75 deaths per 1 million people. This number is slightly lower in the UK at 1.79, but higher in Canada at 6.74. (4) Surgery for intractable epilepsy has been in use for hundreds of years, and in recent decades has demonstrated good success. However, many practitioners and the public still view surgery as a last resort, to be explored only after all possible medical therapy combinations have been exhausted and a good length of time has elapsed. Now, however, many major centers have begun to push surgery further and further to the front of their treatment paradigm, predicated on the discovery that medical refractiveness can be predicted after failure of just a few medications. (1) As collective experience grows, the idea that surgery should be planned early in the disease course is gaining momentum. Now that surgical success rates can top 80% in carefully selected cases (2), the American Academy of Neurology, in association with the American Epilepsy Society and American Association of Neurological Surgeons, after reviewing one class 1 and 24 class 4 studies, recommend referral to an epilepsy center so that patients can be expediently evaluated for surgery. (3) Not only is the length of preoperative disease decreasing in these patients, but they are becoming younger. This raises the question: how early is too early? Even if early intervention makes sense in adults, is there a minimum age for which this holds true? Does intervention before this age cause increased harm? Several studies examining this area were reviewed, which in combination demonstrate that seizure surgery in young patients is efficacious. At Dell Children's Medical Center, we advocate early evaluation and surgery for patients with medically refractory epilepsy who are candidates. In the last two years we have done 17 surgeries on patients under 4 years of age, 3 of which have been on patients under one year. Once a patient is deemed medically refractory with a high likelihood of surgical benefit and acceptable surgical risk, we will proceed with surgery regardless of age. Patient selection, however, requires the coordinated effort of a quality multidisciplinary team.
Export Options
About this article
Cite this article as:
J. Spinks Theodore, R. Lee Mark and Clarke Dave, How Early is Too Early? A Review of Infant Seizure Surgery Literature, Current Pediatric Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339612799746371
DOI https://dx.doi.org/10.2174/157339612799746371 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Progress Towards the Development of DHQO Derivatives and Related Analogues with Inotropic Effects
Mini-Reviews in Medicinal Chemistry Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Targeting of Peripherally Expressed Pain-Related Molecules in Injury- Induced Chronic Neuropathic Pain
CNS & Neurological Disorders - Drug Targets The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
Current Pharmaceutical Design The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly
Current Neuropharmacology Interleukin-4-Induced Oxidative Stress Via Microglial NADPH Oxidase Contributes to the Death of Hippocampal Neurons In Vivo
Current Aging Science Is a "Mitochondrial Psychiatry" in the Future? A Review
Current Psychiatry Reviews Targeting Oxidative Stress Component in the Therapeutics of Epilepsy
Current Topics in Medicinal Chemistry Cannabinoids
Current Drug Targets - CNS & Neurological Disorders Schizophrenia and the Neglect Syndrome: Parietal Contributions to Cognitive Dysfunction in Schizophrenia
Current Psychiatry Reviews Marijuana Use in Young Adults: What Do We Know?
Current Psychopharmacology Needle in a Haystack: Targeting Specific Glucuronidases Amid the Human Microbiome
Current Enzyme Inhibition Book Review: “Dendrites- Third Edition”
CNS & Neurological Disorders - Drug Targets Pregabalin Induced Maculopapular Eruption in an Elderly Male
Current Drug Safety The Role of Topiramate and Other Anticonvulsants in the Treatment of Alcohol Dependence: A Clinical Review
CNS & Neurological Disorders - Drug Targets Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Protein & Peptide Letters Children with Medical Complexity: Forwarding a Policy Agenda
Current Pediatric Reviews Anticonvulsants – Antidepressants Pharmacokinetic Drug Interactions: The Role of the CYP450 System in Psychopharmacology
Current Drug Metabolism Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Mini-Reviews in Medicinal Chemistry Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging